Next Article in Journal
Prognostic Value of Genetic Alterations in Elderly Patients with Acute Myeloid Leukemia: A Single Institution Experience
Previous Article in Journal
MSC.sTRAIL Has Better Efficacy than MSC.FL-TRAIL and in Combination with AKTi Blocks Pro-Metastatic Cytokine Production in Prostate Cancer Cells
Previous Article in Special Issue
NMDA Receptor-Mediated Signaling Pathways Enhance Radiation Resistance, Survival and Migration in Glioblastoma Cells—A Potential Target for Adjuvant Radiotherapy
Article Menu
Issue 4 (April) cover image

Export Article

Open AccessReview

The Role of Platelets in Cancer Pathophysiology: Focus on Malignant Glioma

1
Department of Neurosurgery, University Medicine Greifswald, 17475 Greifswald, Germany
2
Department of Pharmacology, Center of Drug Absorption and Transport, University Medicine Greifswald, 17487 Greifswald, Germany
3
Department of Transfusion Medicine, University Medicine Greifswald, 17475 Greifswald, Germany
*
Author to whom correspondence should be addressed.
Cancers 2019, 11(4), 569; https://doi.org/10.3390/cancers11040569
Received: 27 March 2019 / Revised: 11 April 2019 / Accepted: 18 April 2019 / Published: 22 April 2019
(This article belongs to the Special Issue Glioblastoma: State of the Art and Future Perspectives)
  |  
PDF [978 KB, uploaded 22 April 2019]
  |  

Abstract

The link between thrombocytosis and malignancy has been well known for many years and its associations with worse outcomes have been reported mainly for solid tumors. Besides measuring platelet count, it has become popular to assess platelet function in the context of malignant diseases during the last decade. Malignant gliomas differ tremendously from malignancies outside the central nervous system because they virtually never form distant metastases. This review summarizes the current understanding of the platelet–immune cell communication and its potential role in glioma resistance and progression. Particularly, we focus on platelet-derived proinflammatory modulators, such as sphingosine-1-phosphate (S1P). The multifaceted interaction with immune cells puts the platelet into an interesting perspective regarding the recent advances in immunotherapeutic approaches in malignant glioma. View Full-Text
Keywords: glioblastoma multiforme; platelet; immune cell interaction; sphingosine-1-phosphate glioblastoma multiforme; platelet; immune cell interaction; sphingosine-1-phosphate
Figures

Graphical abstract

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).
SciFeed

Share & Cite This Article

MDPI and ACS Style

Marx, S.; Xiao, Y.; Baschin, M.; Splittstöhser, M.; Altmann, R.; Moritz, E.; Jedlitschky, G.; Bien-Möller, S.; Schroeder, H.W.; Rauch, B.H. The Role of Platelets in Cancer Pathophysiology: Focus on Malignant Glioma. Cancers 2019, 11, 569.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Cancers EISSN 2072-6694 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top